Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma

Mengyun Ke(First Affiliated Hospital of Xi'an Jiaotong University), Jian Dong(Scripps Research Institute), Yi Lv(Shandong Agricultural University), Saisai Wang(Ningbo University of Technology), Yao Zhang(First Affiliated Hospital of Xi'an Jiaotong University), Xiaoning Wu(First Affiliated Hospital of Xi'an Jiaotong University)
Journal of Translational Medicine
May 2, 2019
10.1186/s12967-019-1889-0
Cited by 30

Related Papers

New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment
|Hepatology|2016|156
An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis
|ACS Nano|2023|142
CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1
|Current Biology|1996|138
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019
|BMC Public Health|2024|123
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
|Clinical Gastroenterology and Hepatology|2020|115